Yakira Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Yakira Capital Management’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-177,404	Closed	-$1.7M	–	274
2024 Q4	$1.7M	Buy	+177,404	New	+$926K	0.62%	43

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Yakira Capital Management's PSTX Position: Q1 2025 in Review

Yakira Capital Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 177,404 shares — an estimated $1.7M sold.

Yakira Capital Management first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $1.7M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Yakira Capital Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Yakira Capital Management sold 177,404 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $1.7M.
Yakira Capital Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Yakira Capital Management's Poseida Therapeutics, Inc. Common Stock position peaked at $1.7M in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Yakira Capital Management's 13F filing for Q1 2025, filed 14 May 2025.